The Canadian cannabis market has long-since reached saturation, and stock charts across the sector have been testament to the downturn since March of this year.
But although Canadian producers are grappling with over-supply and largely underwhelmed consumers, the still-developing Latin American market continues to present an opportunity for investors interested in a different market than the flower-dominant markets of Canada and the U.S.
We spoke with Michael Nistorescu, CEO of the soon-to-be-public CannaVerde Pharma, to discuss the slightly-different cannabis markets of Latin America, what constitutes a responsible valuation and how the ‘next cannabis’ may have been under our noses all along.
Listen in!Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
Latest posts by Ethan Reyes (see all)
- SOL Global (SOL.C) files early warning report for acquisition of Torque (GAME.V) shares - November 13, 2019
- Cresco Labs (CL.C) reprices Origin House (OH.C) acquisition terms to match declining market - November 13, 2019
- SpeakEasy Cannabis (EASY.C) still wants to be Canada’s biggest grow and retail investors are buying it - November 12, 2019